{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:29:17Z","timestamp":1767598157535,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","award":["(B)(2)-15390244","(B)-19390209"],"award-info":[{"award-number":["(B)(2)-15390244","(B)-19390209"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health and Labor Sciences Research Grants for Comprehensive Research on Aging and Health","award":["H15-Choju-012"],"award-info":[{"award-number":["H15-Choju-012"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jjcc.2013.05.006","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T15:00:44Z","timestamp":1372690844000},"page":"348-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors"],"prefix":"10.1016","volume":"62","author":[{"given":"Yoshinobu","family":"Kitta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamitsu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Sugamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntarou","family":"Deyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ei","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Kugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2013.05.006_bib0005","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988: role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jjcc.2012.06.008","article-title":"The relationship of angiographically defined coronary artery disease with insulin sensitivity and secretion in subjects with different glucose tolerance","volume":"61","author":"Wang","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1464-5491.2002.00719.x","article-title":"Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death","volume":"19","author":"Hedblad","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/dc09-2110","article-title":"Insulin resistance predicts mortality in nondiabetic individuals in the US","volume":"33","author":"Ausk","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0735-1097(02)02848-6","volume":"41","author":"Gibbons","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0735-1097(01)01682-5","article-title":"AHA\/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology","volume":"38","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0040","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0735-1097(02)02982-0","article-title":"Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease","volume":"41","author":"Reaven","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5551\/jat.14.122","article-title":"Effect of therapeutic lifestyle changes on insulin sensitivity of non-obese hyperlipidemic subjects: preliminary report","volume":"14","author":"Al-Mahmood","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0050","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.5551\/jat.5959","article-title":"Impact of changes in obesity parameters on glucose metabolism and insulin resistance over a once-year period","volume":"17","author":"Sakamoto","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.amepre.2011.06.042","article-title":"Dietary weight loss and exercise effects on insulin resistance in postmenopausal women","volume":"41","author":"Mason","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.07.023","article-title":"Rapid improvement of carotid plaque echogenicity within 1 month of pioglitazone treatment in patients with acute coronary syndrome","volume":"203","author":"Hirano","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0065","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.54.8.2404","article-title":"Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program. Effects of lifestyle intervention and metformin","volume":"54","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(01)00382-0","article-title":"Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate vs atorvastatin trial-FAT)","volume":"52","author":"Malik","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0075","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2169\/internalmedicine.46.7173","article-title":"Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome","volume":"46","author":"Ichikawa","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jjcc.2012.07.010","article-title":"The effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load","volume":"60","author":"Hiramitsu","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0090","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.25.7.1177","article-title":"Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease","volume":"25","author":"Hanley","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetic Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1464-5491.2002.00719.x","article-title":"Insulin resistance in non-diabetic subjects is associated with incidence of myocardial infarction and death","volume":"19","author":"Hedblad","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/dc06-0919","article-title":"Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population","volume":"30","author":"Bonora","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0110","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.2337\/diabetes.54.11.3252","article-title":"Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study","volume":"54","author":"Rutter","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc06-2484","article-title":"Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome","volume":"30","author":"Meigs","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0120","doi-asserted-by":"crossref","first-page":"762e1","DOI":"10.1016\/j.ahj.2007.02.022","article-title":"Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome","volume":"153","author":"Katayama","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0125","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","article-title":"New criteria for obesity disease in Japan","volume":"66","author":"The Examination Committee of Criteria for Obesity Disease in Japan","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0135","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.97.25.2519","article-title":"Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries","volume":"97","author":"Kugiyama","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.20.7.1087","article-title":"The homeostasis model in the San Antonio Heart study","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control on type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0150","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/eurheartj\/ehr077","article-title":"Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study","volume":"32","author":"Schramm","year":"2011","journal-title":"Eur Heart"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0155","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (prospective pioglitazone clinical trial in macrovascular events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2013.05.006_bib0160","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:51:35Z","timestamp":1760273495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508713001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0914508713001676"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.05.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"type":"print","value":"0914-5087"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}